The DOI matches its Crossref record; 523 of the 523 references it cites were found in a registry or an index.
Regulation and metabolic functions of mTORC1 and mTORC2
Open accessAbstract
Cells metabolize nutrients for biosynthetic and bioenergetic needs to fuel growth and proliferation. The uptake of nutrients from the environment and their intracellular metabolism is a highly controlled process that involves cross talk between growth signaling and metabolic pathways. Despite constant fluctuations in nutrient availability and environmental signals, normal cells restore metabolic homeostasis to maintain cellular functions and prevent disease. A central signaling molecule that integrates growth with metabolism is the mechanistic target of rapamycin (mTOR). mTOR is a protein kinase that responds to levels of nutrients and growth signals. mTOR forms two protein complexes, mTORC1, which is sensitive to rapamycin, and mTORC2, which is not directly inhibited by this drug. Rapamycin has facilitated the discovery of the various functions of mTORC1 in metabolism. Genetic models that disrupt either mTORC1 or mTORC2 have expanded our knowledge of their cellular, tissue, as well as systemic functions in metabolism. Nevertheless, our knowledge of the regulation and functions of mTORC2, particularly in metabolism, has lagged behind. Since mTOR is an important target for cancer, aging, and other metabolism-related pathologies, understanding the distinct and overlapping regulation and functions of the two mTOR complexes is vital for the development of more effective therapeutic strategies. This review discusses the key discoveries and recent findings on the regulation and metabolic functions of the mTOR complexes. We highlight findings from cancer models but also discuss other examples of the mTOR-mediated metabolic reprogramming occurring in stem and immune cells, type 2 diabetes/obesity, neurodegenerative disorders, and aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Items 401–523 of 523
Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming
Nishimura, K., Fukuda, A., & Hisatake, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092254 · Cited by 75
PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes
Li, C., Li, Y., He, L., Agarwal, A., Zeng, N., Cadenas, E., & Stiles, B. L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.013 · Cited by 74
Wu, X., Wang, X., Wu, S., Lu, J., Zheng, M., Wang, Y., Zhou, H., Zhang, H., & Han, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.233122 · Cited by 73
Fan, S.-J., Snell, C. E., Turley, H., Li, J., McCormick, R. D., Perera, S., Heublein, S., Kazi, S., Azad, A. K., WILSON, C. G., et al. (2015) · Oncogene · doi:10.1038/onc.2015.363 · Cited by 71
Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis
Viscarra, J. A., Wang, Y., Nguyen, H. P., Choi, Y. G., & Sul, H. S. (2020) · Nature Communications · doi:10.1038/s41467-020-14617-1 · Cited by 71
Rapamycin induces Smad activity in prostate cancer cell lines
van der Poel, H. G., Hanrahan, C. F., Zhong, H., & Simons, J. W. (2003) · Urological Research · doi:10.1007/s00240-002-0282-1 · Cited by 70
Smith, M. A., Katsouri, L., Irvine, E. E., Hankir, M. K., Pedroni, S. M. A., Voshol, P. J., Gordon, M. W., Choudhury, A. I., Woods, A., Vidal‐Puig, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.029 · Cited by 69
Zhao, X., Petrashen, A. P., Sanders, J. A., Peterson, A. L., & Sedivy, J. M. (2019) · Aging Cell · doi:10.1111/acel.12947 · Cited by 69
Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
Wang, Q., Zhu, J., Wang, Y.-W., Dai, Y., Wang, Y.-L., Wang, C., Liu, J., Baker, A., Colburn, N. H., & Yang, H.-S. (2017) · Oncogene · doi:10.1038/onc.2017.228 · Cited by 67
Makki, K., Taront, S., Molendi‐Coste, O., Bouchaert, E., Neve, B., Eury, E., Lobbens, S., Labalette, M., Duez, H., Staels, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092684 · Cited by 67
Cerniglia, G. J., Dey, S., Gallagher‐Colombo, S. M., Daurio, N. A., Tuttle, S. W., Busch, T. M., Lin, A., Sun, R. C., Esipova, T. V., Vinogradov, S. A., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0888 · Cited by 67
The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond
Lee, P. L., Jung, S. M., & Guertin, D. A. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.01.004 · Cited by 66
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Buj, R., Chen, C., Dahl, E. S., Leon, K. E., Kuskovsky, R., Maglakelidze, N., Navaratnarajah, M., Zhang, G., Doan, M. T., Jiang, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.084 · Cited by 66
The Phosphatidylinositol 3-Kinase/Akt Cassette Regulates Purine Nucleotide Synthesis
Wang, W., Fridman, A., Blackledge, W., Connelly, S., Wilson, I. A., Pilz, R. B., & Boss, G. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806707200 · Cited by 65
mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival
Feng, Y., & Wu, L.-S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.031 · Cited by 65
Gleason, C. E., Osés-Prieto, J. A., Li, K. H., Saha, B., Situ, G., Burlingame, A. L., & Pearce, D. (2019) · Journal of Cell Science · doi:10.1242/jcs.224931 · Cited by 63
Hypothalamic mTORC2 is essential for metabolic health and longevity
Chellappa, K., Brinkman, J. A., Mukherjee, S., Morrison, M., Alotaibi, M. I., Carbajal, K. A., Alhadeff, A. L., Perron, I. J., Yao, R., Purdy, C. S., et al. (2019) · Aging Cell · doi:10.1111/acel.13014 · Cited by 62
Raptor is Phosphorylated by cdc2 during Mitosis
Gwinn, D. M., Asara, J. M., & Shaw, R. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009197 · Cited by 61
Evert, M., Calvisi, D. F., Evert, K., Murtas, V. D., Gasparetti, G., Mattu, S., Destefanis, G., Ladu, S., Zimmermann, A., Delogu, S., et al. (2012) · Hepatology · doi:10.1002/hep.25600 · Cited by 61
NLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibitionPreprint
Yuan, H.-X., Wang, Z., Yu, F., Li, F., Russell, R. C., Jewell, J. L., & Guan, K. (2015) · Genes & Development · doi:10.1101/gad.265116.115 · Cited by 61
Cross regulation between mTOR signaling and O-GlcNAcylation
Very, N., Steenackers, A., Dubuquoy, C., Vermuse, J., Dubuquoy, L., Lefebvre, T., & Yazidi‐Belkoura, I. E. (2018) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-018-9747-y · Cited by 61
Lorberg, A., & Hall, M. N. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_1 · Cited by 60
Mammalian target of rapamycin complex 2 regulates muscle glucose uptake during exercise in mice
Kleinert, M., Parker, B. L., Fritzen, A. M., Knudsen, J. R., Jensen, T. E., Kjøbsted, R., Sylow, L., Ruegg, M., James, D. E., & Richter, E. A. (2017) · The Journal of Physiology · doi:10.1113/jp274203 · Cited by 59
Wang, Y., Wang, Y., Shen, L., Pang, Y., QIAO, Z., & Liu, P. (2012) · Oncology Reports · doi:10.3892/or.2012.1638 · Cited by 59
Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF–mediated myelopoiesis
Karmaus, P. W. F., Herrada, A. A., Guy, C. S., Neale, G. A. M., Dhungana, Y., Long, L., Vogel, P., Ávila-Pacheco, J., Clish, C. B., & Chi, H. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161855 · Cited by 59
Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2
Karuppasamy, M., Kuśmider, B., de Oliveira, T. M., Gaubitz, C., Prouteau, M., Loewith, R., & Schaffitzel, C. (2017) · Nature Communications · doi:10.1038/s41467-017-01862-0 · Cited by 59
Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration
Nguyen, J. T., Ray, C., Fox, A. L., Mendonça, D. B. S., Kim, J. K., & Krebsbach, P. H. (2018) · Science Advances · doi:10.1126/sciadv.aao5838 · Cited by 58
Arif, T., Paul, A., Krelin, Y., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2018) · Cancers · doi:10.3390/cancers10120499 · Cited by 58
Insulin and Autophagy in Neurodegeneration
de Mello, N. P., Orellana, A. M., Mazucanti, C. H., Lima, G. D. M., Scavone, C., & Kawamoto, E. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00491 · Cited by 58
The GATOR2–mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation
Kowalsky, A. H., Namkoong, S., Mettetal, E., Park, H., Kazyken, D., Fingar, D. C., & Lee, J. H. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010857 · Cited by 58
Lee, H.-K., Kwon, B., Lemere, C. A., de la Monte, S., Itamura, K., Ha, A. Y., & Querfurth, H. W. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161029 · Cited by 57
Lu, M., Wang, J., Ives, H. E., & Pearce, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257592 · Cited by 57
The small GTPases Ras and Rap1 bind to and control TORC2 activity
Khanna, A., Lotfi, P., Chavan, A. J., Montaño, N. M., Bolourani, P., Weeks, G., Shen, Z., Briggs, S. P., Pots, H., Haastert, P. J. M. V., et al. (2016) · Scientific Reports · doi:10.1038/srep25823 · Cited by 56
Singh, B. K., Sinha, R. A., Zhou, J., Tripathi, M., Ohba, K., Wang, M., Astapova, I. I., Ghosh, S., Hollenberg, A. N., Gauthier, K. C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668673 · Cited by 55
The lysosomal GPCR-like protein GPR137B regulates Rag and mTORC1 localization and activity
Gan, L., Seki, A., Shen, K., Iyer, H., Han, K., Hayer, A., Wollman, R., Ge, X., Lin, J. R., Dey, G., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0321-6 · Cited by 55
Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1
Wallroth, A., Koch, P. A., Marat, A. L., Krause, E., & Haucke, V. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0377-3 · Cited by 55
Hwang, Y., Kim, L. C., Song, W., Edwards, D. N., Cook, R. S., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3658 · Cited by 54
Dutchak, P. A., Estill-Terpack, S. J., Plec, A. A., Zhao, X., Yang, C., Chen, J., Ko, B., Deberardinis, R. J., Yu, Y., & Tu, B. P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.058 · Cited by 53
Stimulation of Somatic Cell Reprogramming by ERas-Akt-FoxO1 Signaling Axis
Yu, Y., Liang, D., Tian, Q., Chen, X., Jiang, B., Chou, B.-K., Hu, P., Cheng, L., Gao, P., Li, J., et al. (2013) · Stem Cells · doi:10.1002/stem.1447 · Cited by 53
Chen, H.-H., Huang, W., Yang, L., & Lin, C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.025 · Cited by 52
The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
Merhi, A., Delrée, P., & Marini, A. M. (2017) · Scientific Reports · doi:10.1038/srep44602 · Cited by 51
Fission yeast Ryh1 GTPase activates TOR Complex 2 in response to glucose
Hatano, T., Morigasaki, S., Tatebe, H., Ikeda, K., & Shiozaki, K. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000215 · Cited by 50
The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose Uptake
Jiang, X., Kenerson, H. L., Aicher, L. D., Miyaoka, R. S., Eary, J. F., Bissler, J. J., & Yeung, R. S. W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070958 · Cited by 50
Holmes, B., Benavides-Serrato, A., Freeman, R. S., Landon, K. A., Bashir, T., Nishimura, R. N., & Gera, J. (2017) · Oncogene · doi:10.1038/onc.2017.360 · Cited by 50
Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction
Colombi, M., Molle, K. D., Benjamin, D., Rattenbacher-Kiser, K. F., Schaefer, C., Betz, C., Thiemeyer, A., Regenass, U., Hall, M. N., & Moroni, C. (2010) · Oncogene · doi:10.1038/onc.2010.539 · Cited by 48
mTORC2 Is Required for Rit-Mediated Oxidative Stress Resistance
Cai, W., & Andres, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115602 · Cited by 48
Effects of rapamycin on growth hormone receptor knockout mice
Fang, Y., Hill, C. M., Darcy, J., Reyes‐Ordoñez, A., Arauz, E. J., McFadden, S., Zhang, C., Osland, J. M., Gao, J., Zhang, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717065115 · Cited by 48
Yao, Y., Suraokar, M., Darnay, B. G., Hollier, B. G., Shaiken, T. E., Asano, T., Chen, C.-H., Chang, B. H.-J., Lu, Y., Mills, G. B., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003295 · Cited by 47
Inhibition of mTOR affects protein stability of OGT
Park, S. Y., Pak, J. W., Jang, I., & Cho, J. W. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.047 · Cited by 47
Rosario, F. J., Powell, T. L., & Jansson, T. (2016) · Scientific Reports · doi:10.1038/srep31705 · Cited by 47
Manning, J. R., Thapa, D., Zhang, M., Stoner, M. W., Traba, J., Corey, C. G., Shiva, S., Sack, M. N., & Scott, I. (2019) · Biochemical Journal · doi:10.1042/bcj20190302 · Cited by 47
Kwak, D., Choi, S., Jeong, H., Jang, J., Lee, Y., Jeon, H., Lee, M. N., Noh, J., Cho, K., Yoo, J. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.326538 · Cited by 46
Moloughney, J. G., Vega-Cotto, N. M., Liu, S., Patel, C., Kim, P. K., Wu, C., Albaciete, D., Magaway, C., Chang, A. B., Rajput, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003991 · Cited by 45
Self-citationCordover, E., Wei, J., Patel, C., Shan, N. L., Gionco, J. T., Sargsyan, D., Wu, R., Cai, L., Kong, A. T., Jacinto, E., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00376 · Cited by 45
Self-citationGuo, L., Zhou, B. O., Liu, Z., Xu, Y., Lü, H., Xia, M., Guo, E., Shan, W., Chen, G., & Wang, C. (2016) · Tumor Biology · doi:10.1007/s13277-016-4984-3 · Cited by 44
The role of mTOR in lipid homeostasis and diabetes progression
Chakrabarti, P., & Kandror, K. V. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000187 · Cited by 44
Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
Espíndola‐Netto, J. M., Chini, C. C. S., Tarragó, M. G., Wang, E., Dutta, S. K., Pal, K., Mukhopadhyay, D., Sola‐Penna, M., & Chini, E. N. (2017) · Oncotarget · doi:10.18632/oncotarget.18841 · Cited by 44
Martineau, Y., Wang, X., Alain, T., Petroulakis, E., Shahbazian, D., Fabre, B., Bousquet, M., Monsarrat, B., Pyronnet, S., & Sonenberg, N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01079-13 · Cited by 43
Smithson, L. J., & Gutmann, D. H. (2016) · Genes & Development · doi:10.1101/gad.279661.116 · Cited by 43
Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids
Frias, M. A., Mukhopadhyay, S., Lehman, E., Walasek, A., Utter, M., Menon, D., & Foster, D. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010892 · Cited by 43
Rapamycin and Dietary Restriction Induce Metabolically Distinctive Changes in Mouse Liver
Yu, Z., Wang, R., Fok, W. C., Coles, A., Salmon, A. B., & Pérez, V. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu053 · Cited by 42
Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism
Guridi, M., Kupr, B., Romanino, K., Lin, S., Falcetta, D., Tintignac, L. A. J., & Rüegg, M. A. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0084-8 · Cited by 42
TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877
Antonia, R. J., Cabrera, J. C., Herring, L. E., Serafín, D., Liu, P., Graves, L. M., Baldwin, A. S., & Hagan, R. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49707-8 · Cited by 42
Shaw, E., Talwadekar, M., Rashida, Z., Mohan, N., Acharya, A., Khatri, S., Laxman, S., & Kolthur‐Seetharam, U. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00212-19 · Cited by 42
Raptor determines β-cell identity and plasticity independent of hyperglycemia in mice
Yin, Q., Ni, Q., Wang, Y., Zhang, H., Li, W., Nie, A., Wang, S., Gu, Y., Wang, Q., & Ning, G. (2020) · Nature Communications · doi:10.1038/s41467-020-15935-0 · Cited by 42
Chemical Genetics of Rapamycin-Insensitive TORC2 in S. cerevisiae
Kliegman, J. I., Fiedler, D., Ryan, C. J., Xu, Y.-F., Su, X., Thomas, D. M., Caccese, M., Cheng, A., Shales, M., Rabinowitz, J. D., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.040 · Cited by 41
Zhang, C., Skamagki, M., Liu, Z., Ananthanarayanan, A., Zhao, R., Li, H., & Kim, K. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.098 · Cited by 41
Dong, Q., Majumdar, G., O’Meally, R. N., Cole, R. N., Elam, M. B., & Raghow, R. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03625-5 · Cited by 40
IKK interacts with rictor and regulates mTORC2
Xu, Y., Lai, E.-Y., Liu, J., Lin, J., Yang, C., Jia, C., Li, Y., Bai, X., & Li, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.008 · Cited by 39
Chen, C.-H., Kiyan, V. S., Zhylkibayev, A. A., Kazyken, D., Bulgakova, O., Page, K. E., Bersimbaev, R. I., Spooner, E., & Sarbassov, D. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498055 · Cited by 39
microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells
Cui, Y., Zhao, J., Yi, L., & Jiang, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156915 · Cited by 39
Metabolic aspects of neuronal degeneration: From a NAD+ point of view
Sasaki, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.001 · Cited by 39
The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes
Chiu, H., Jackson, L. V., Oh, K. I., Mai, A., Ronai, Z. A., Ruggero, D., & Fruman, D. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800602 · Cited by 39
Divergent Metabolic Regulation of Autophagy and mTORC1—Early Events in Alzheimer’s Disease?
Shafei, M. A., Harris, M., & Conway, M. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00173 · Cited by 38
Wang, T., Zhang, W., Wang, Z., Wu, Z., Du, B., Li, L., Chen, Y., Yang, X., Hao, X., & Guo, T. (2019) · Cancer Medicine · doi:10.1002/cam4.2810 · Cited by 38
Jones, D. R., Keune, W., Anderson, K. E., Stephens, L., Hawkins, P. T., & Divecha, N. (2014) · FEBS Journal · doi:10.1111/febs.12879 · Cited by 37
Swindell, W. R. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw153 · Cited by 37
Yang, C., Melhuish, T. A., Spencer, A., Li, N., Hao, Y., Jividen, K., Harris, T. E., Snow, C. J., Frierson, H. F., Wotton, D., et al. (2017) · The Prostate · doi:10.1002/pros.23400 · Cited by 37
Identification and characterization of two novel oncogenic mTOR mutations
Murugan, A. K., Liu, R., & Xing, M. (2019) · Oncogene · doi:10.1038/s41388-019-0787-5 · Cited by 37
Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1 gene
Schroder, W. A., Cloonan, N., Bushell, G. R., & Sculley, T. B. (2004) · Gene · doi:10.1016/j.gene.2004.07.001 · Cited by 36
Mediobasal hypothalamic overexpression of DEPTOR protects against high-fat diet-induced obesity
Caron, A., Labbé, S. M., Lanfray, D., Blanchard, P.-G., Villot, R., Roy, C., Sabatini, D. M., Richard, D., & Laplante, M. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.11.005 · Cited by 36
The role of RICTOR amplification in targeted therapy and drug resistance
Zhao, D., Jiang, M., Zhang, X., & Hou, H. (2020) · Molecular Medicine · doi:10.1186/s10020-020-0146-6 · Cited by 36
Vadla, R., & Haldar, D. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1404207 · Cited by 35
RagC phosphorylation autoregulates mTOR complex 1
Yang, G., Humphrey, S. J., Murashige, D., Francis, D., Wang, Q., Cooke, K. C., Neely, G. G., & James, D. E. (2018) · The EMBO Journal · doi:10.15252/embj.201899548 · Cited by 35
Akt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen
Zhang, Y., & Stefanovic, B. (2016) · Scientific Reports · doi:10.1038/srep22597 · Cited by 34
den Hartigh, L. J., Goodspeed, L., Wang, S. A., Kenerson, H. L., Omer, M., O’Brien, K. D., Ladiges, W., Yeung, R. S. W., & Subramanian, S. (2018) · Experimental Physiology · doi:10.1113/ep087207 · Cited by 34
Drusian, L., Nigro, E. A., Mannella, V., Pagliarini, R., Pema, M., Costa, A. S. H., Benigni, F., Larcher, A., Chiaravalli, M., Gaude, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.106 · Cited by 33
CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways
Xu, W., Hua, H., Chiu, Y.-H., Li, G., Zhi, H., Yu, Z., Ren, F., Luo, Y., & Cui, W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.047 · Cited by 32
Haissaguerre, M., Ferrière, A., Simon, V., Saucisse, N., Dupuy, N., André, C., Clark, S., Guzmán‐Quevedo, O., Tabarin, A., & Cota, D. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.04.002 · Cited by 31
Sin1/mTORC2 regulate B cell growth and metabolism by activating mTORC1 and Myc
Li, M., Lazorchak, A. S., Ouyang, X., Zhang, H., Liu, H., Arojo, O., Yan, L., Jin, J., Han, Y., Qu, G., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0185-x · Cited by 31
Mpilla, G., Aboukameel, A., Muqbil, I., Kim, S. H., Beydoun, R., Philip, P. A., Mohammad, R. M., Kamgar, M., Shidham, V. B., Senapedis, W. T., et al. (2019) · Cancers · doi:10.3390/cancers11121902 · Cited by 31
4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL
Singh, M., Shin, Y., Yang, X., Zehr, B., Chakrabarti, P., & Kandror, K. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.631895 · Cited by 30
Yao, C., Ortiz-Vega, S., Sun, Y.-Y., Chien, C., Chuang, J.-H., & Lin, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18818 · Cited by 29
He, J., Yang, Y., Zhang, J., Chen, J.-Z., Wei, X., He, J., & Luo, L. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.09.013 · Cited by 29
Metabolic regulation of T cell development by Sin1–mTORC2 is mediated by pyruvate kinase M2
Ouyang, X., Han, Y., Qu, G., Li, M., Wu, N., Liu, H., Arojo, O., Sun, H., Liu, X., Liu, D., et al. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy065 · Cited by 29
Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer
Yamaguchi, H., Kawazu, M., Yasuda, T., Soda, M., Ueno, T., Kojima, S., Yashiro, M., Yoshino, I., Ishikawa, Y., Sai, E., et al. (2015) · Cancer Science · doi:10.1111/cas.12828 · Cited by 28
RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition
Earwaker, P., Anderson, C. J., Willenbrock, F. W., Harris, A. L., Protheroe, A. S., & Macaulay, V. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191890 · Cited by 28
Characterization of Sin1 Isoforms Reveals an mTOR-Dependent and Independent Function of Sin1γ
Yuan, Y., Pan, B., Sun, H., Chen, G., Su, B., & Huang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135017 · Cited by 27
Nakashima, A., Kawanishi, I., Eguchi, S., Yu, E. H., Eguchi, S., Oshiro, N., Yoshino, K., Kikkawa, U., & Yonezawa, K. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-24 · Cited by 27
Pal, R., Xiong, Y., & Sardiello, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812943116 · Cited by 26
Direct physical interaction of active Ras with mSIN1 regulates mTORC2 signaling
Lone, M. D., Miyan, J., Asif, M., Malik, S. A., Dubey, P., Singh, V., Singh, K., Mitra, K., Pandey, D., Haq, W., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6422-6 · Cited by 25
Coffman, K., Yang, B., Lu, J., Tetlow, A. L., Pelliccio, E., Lu, S., Guo, D., Tang, C., Dong, M., & Tamanoi, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482067 · Cited by 24
Zhan, J., Chitta, R. K., Harwood, F. C., & Grosveld, G. C. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03498-8 · Cited by 24
NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer’s Disease
Bellozi, P. M. Q., Gomes, G. F., de Oliveira, L. R., Olmo, I. G., Vieira, É. L. M., Ribeiro, F. M., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01345 · Cited by 22
Zhou, P., Zhang, N., Nussinov, R., et al. (2015) · Journal of Computational Biology · doi:10.1089/cmb.2015.0103 · Cited by 21
Qian, J., Chen, Y., Meng, T., Ma, L., Meng, L., Wang, X., Yu, T., Zask, A., Shen, J., & Yu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.11490 · Cited by 19
Li, Y., He, Z., Liu, Q., Zhou, K., Shi, Y., Yao, X., Zhang, X., Kung, H., Ping, Y., & Bian, X. (2018) · Journal of Cancer · doi:10.7150/jca.20869 · Cited by 18
Caron, A., Labbé, S. M., Mouchiroud, M., Huard, R., Richard, D., & Laplante, M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00549.2015 · Cited by 17
McKenna, J., Kapfhamer, D., Kinchen, J. M., Wasek, B. L., Dunworth, M., Stewart, T. M., Bottiglieri, T., Casero, R. A., & Gambello, M. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy118 · Cited by 17
Soliman, G. A. (2016) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000183 · Cited by 16
Xie, Y., Cui, C., Nie, A., Wang, Y., Ni, Q., Liu, Y., Yin, Q., Zhang, H., Li, Y., Wang, Q., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.04.008 · Cited by 16
The clinical course and potential underlying mechanisms of everolimus-induced hyperglycemia
Tanimura, J., Nakagawa, H., Tanaka, T., Kikuchi, A., Osada, S., Tanaka, Y., Tokuyama, K., & Takamura, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0542 · Cited by 16
Guo, Z., Zhao, K., Feng, X., et al. (2019) · BioMed Research International · doi:10.1155/2019/5196028 · Cited by 16
Zucal, C., D’Agostino, V., Casini, A., Mantelli, B., Thongon, N., Soncini, D., Caffa, I., Cea, M., Ballestrero, A., Quattrone, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1845-1 · Cited by 15
Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue
Chia, L. Y., Evans, B. A., Mukaida, S., Bengtsson, T., Hutchinson, D. S., & Sato, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14616 · Cited by 15
mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation
Chou, P.-C., Rajput, S., Zhao, X., Patel, C., Albaciete, D., Oh, W. J., Queen, H., Patel, N., Su, B., Werlen, G., et al. (2020) · Cells · doi:10.3390/cells9071567 · Cited by 15
Self-citationInvolvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells in vitro
Zheng, B., Wang, J., Tang, L., Tan, C., Zhao, Z., Xiao, Y., Ge, R., & Zhu, D. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.16312 · Cited by 14
Abetov, D. A., Kiyan, V. S., Zhylkibayev, A. A., Sarbassova, D. A., Alybayev, S., Spooner, E., Song, M. S., Bersimbaev, R. I., & Sarbassov, D. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ac119.008378 · Cited by 13
Amplifying mTORC2 signals through AMPK during energetic stress
Jacinto, E. (2019) · Science Signaling · doi:10.1126/scisignal.aax5855 · Cited by 13
Self-citationModulation of hypothalamic S6K1 and S6K2 alters feeding behavior and systemic glucose metabolism
Tavares, M. R., Lemes, S. F., de Fante, T., de Miera, C. S., Pavan, I. C. B., Bezerra, R. M. N., Prada, P. O., Torsoni, M. A., Elias, C. F., & Simabuco, F. M. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0364 · Cited by 13
Loss of TSC complex enhances gluconeogenesis via upregulation of Dlk1-Dio3 locus miRNAs
Liko, D., Rzepiela, A. J., Vukojević, V., Zavolan, M., & Hall, M. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918931117 · Cited by 13
Ni, Q., Song, J., Wang, Y., Sun, J., Xie, J., Zhang, J., Ning, G., Wang, W., & Wang, Q. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa786 · Cited by 13
The Target of Rapamycin: Structure and Functions
Wu, C., Chou, P., & Jacinto, E. (2012) · InTech eBooks · doi:10.5772/37927 · Cited by 8
Self-citation
Cited by
Chronic inflammation and the hallmarks of aging
Baechle, J. J., Chen, N., Makhijani, P., Winer, S., Furman, D., & Winer, D. A. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101755 · Cited by 471
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
The AMPK pathway in fatty liver disease
Fang, C., Pan, J., Qu, N., Lei, Y., Han, J., Zhang, J., & Han, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.970292 · Cited by 364
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
LIM, C., NUNES, E. A., CURRIER, B. S., MCLEOD, J. C., THOMAS, A. C. Q., & PHILLIPS, S. M. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002929 · Cited by 142
Metadata
- Authors
- Szwed, A., Kim, E., & Jacinto, E.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2021-07-01
- Volume
- 101
- Issue
- 3
- Pages
- 1371-1426
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W3132255180
- Cited by
- 813
- References
- 523
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.